S&P 500
(-1.47%) 4 273.53 points
Dow J
(-1.14%) 33 619 points
(-1.57%) 13 064 points
(0.90%) $91.20
(-0.08%) $2.65
(0.04%) $1 920.60
(-0.48%) $23.09
(0.29%) 909.70
(0.09%) 0.946
(0.07%) 10.82
(0.07%) 0.823
(2.52%) 96.58

Realtime updates for Luminex Corporation [LMNX]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Instruments & Supplies
Last Updated31 Dec 1970 @ 19:00

0.00% $ 36.99

Live Chart Being Loaded With Signals

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide...

Today's Volume 1.02M
Average Volume 650 237
Market Cap 0.00
EPS $0.0400
Earnings date 2020-11-05
P/E 0
ATR14 $0.188 (0.51%)

Volume Correlation

Long: 0.06 (neutral)
Short: 0.88 (strong)
Signal:(63.839) Same movement expected

Luminex Corporation Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Luminex Corporation Correlation - Currency/Commodity

The country flag 0.71
( moderate )
The country flag -0.33
( neutral )
The country flag -0.74
( moderate negative )
The country flag 0.63
( weak )
The country flag 0.45
( neutral )
The country flag 0.46
( neutral )

Luminex Corporation Financials

Annual 2020
Revenue: $417.40M
Gross Profit: $247.85M (59.38%)
EPS: $0.336
Q1 2021
Revenue: $110.69M
Gross Profit: $66.46M (60.04%)
EPS: $0.190
Q4 2020
Revenue: $111.39M
Gross Profit: $64.44M (57.85%)
EPS: $0.0053
Q3 2020
Revenue: $106.06M
Gross Profit: $63.38M (59.76%)
EPS: $0.0400

Luminex Corporation Financials DIVIDENDS

(Q3/19) 2019-09-25 (Q4/19) 2019-12-18 (Q1/20) 2020-03-18 (Q2/20) 2020-06-17 (Q3/20) 2020-09-23 (Q4/20) 2020-12-22 (Q1/21) 2021-03-24 (Q2/21) 2021-06-16
(Paid: 2019-10-17)
(Paid: 2020-01-15)
(Paid: 2020-04-09)
(Paid: 2020-07-09)
(Paid: 2020-10-15)
(Paid: 2021-01-14)
(Paid: 2021-04-15)
(Paid: 2021-07-08)

Luminex Corporation

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.

LMNX Next Dividend
(2023-12-13) $0.101 Probabilty 100 %

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators


"Getagraph.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "Getagraph.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.
Total Execution Time: 3.9552221298218 seconds
Number of API calls: 1
Number of DB calls: 10